step 6 semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial Semaglutide & Tirzepatide Weekly Dose

It has been confirmed that patients with T2DM have a higher risk of developing NDD, including AD, PD, amyotrophic lateral sclerosis and Huntingtons disease, which in these patients are accompanied by more pronounced motor deficits and faster disease progression

Trends in cardiovascular medicine , 33(3), 159166

Patient:innen, die medizinisch profitieren wrden, verzichten auf eine wirksame Therapie aus Angst, die auf unvollstndigen Informationen beruht

Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism

Nebbioso M, Evangelista M, Librando A, Plateroti AM, Pescosolido N